This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for MYLOTARG® (gemtuzumab ozogamicin) Great Britain (GB) Northern Ireland (NI) and Cytarabine (UK) ​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Mylotarg (gemtuzumab ozogamicin) - 5mg powder for concentrate for solution for infusion - PI for GB

Northern Ireland

  • Mylotarg (gemtuzumab ozogamicin) - 5mg powder for concentrate for solution for infusion - PI for NI

United Kingdom

  • Cytarabine - 100mg/ml - PI for UK
  • Cytarabine 100mg/ml injection solution - PI for UK 
  • Cytarabine 20mg/ml injection solution - PI for UK 

Mylotarg (gemtuzumab ozogamicin) - 5mg powder for concentrate for solution for infusion - PI for GB

Mylotarg (gemtuzumab ozogamicin) - 5mg powder for concentrate for solution for infusion - PI for NI

Cytarabine - 100mg/ml - PI for UK

Cytarabine 100mg/ml injection solution - PI for UK 

Cytarabine 20mg/ml injection solution - PI for UK 

PP-MYL-GBR-0815. August 2023